Human cardiac microtissues for modelling disease and ageing: from Friedreich’s ataxia to the ageing heart
Human induced pluripotent stem cell (iPSC)-derived cardiac models offer a scalable platform for studying heart disease and testing therapies. This seminar will present two applications of this approach. First, a drug testing pipeline for Friedreich’s ataxia (FRDA) cardiomyopathy, in which patient-derived and isogenic control cardiomyocytes, non-myocyte populations and multicellular cardiac spheroids are used to evaluate candidate compounds, including omaveloxolone, vatiquinone and elamipretide (SS-31), across measures of viability, mitochondrial stress and contractile function. Second, a model of the ageing heart driven by progerin, and how it will be used to identify treatments that slow or reverse cardiac ageing.
About the speaker: Dr Sebastian Bass-Stringer is a Senior Research Officer at St Vincent’s Institute of Medical Research. He completed his PhD in cardiac biology at La Trobe University and the Baker Heart and Diabetes Institute in 2022, then worked at the Murdoch Children’s Research Institute before joining SVI in 2025. His research uses human stem cell-derived cardiac models to study heart disease and ageing, with a focus on developing new therapies. He has received the 2026 ASSCR Rising Star Award and an SVI Rising Star Award.Dr Sebastian Bass-Stringer is a Senior Research Officer at St Vincent’s Institute of Medical Research. He completed his PhD in cardiac biology at La Trobe University and the Baker Heart and Diabetes Institute in 2022, then worked at the Murdoch Children’s Research Institute before joining SVI in 2025. His research uses human stem cell-derived cardiac models to study heart disease and ageing, with a focus on developing new therapies. He has received the 2026 ASSCR Rising Star Award and an SVI Rising Star Award.
Join us: Tuesday 27 October, 12:00pm, ACMD Auditorium, Level 1, 27 Victoria Parade, Fitzroy (enter via Nicholson Street)







